Oxford Nanopore Technologies (LON:ONT – Get Free Report)‘s stock had its “hold” rating reaffirmed by Peel Hunt in a research report issued to clients and investors on Monday,London Stock Exchange reports. They presently have a GBX 153 price objective on the stock. Peel Hunt’s target price would indicate a potential upside of 36.36% from the company’s current price.
Other research analysts have also issued research reports about the stock. Berenberg Bank cut their price target on shares of Oxford Nanopore Technologies from GBX 230 to GBX 220 and set a “buy” rating on the stock in a research note on Monday. Royal Bank Of Canada reissued an “outperform” rating and set a GBX 225 price objective on shares of Oxford Nanopore Technologies in a research report on Tuesday, May 26th. Finally, Citigroup lowered shares of Oxford Nanopore Technologies to a “buy” rating in a report on Friday. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of GBX 212.60.
Read Our Latest Report on Oxford Nanopore Technologies
Oxford Nanopore Technologies Trading Down 6.7%
Insider Transactions at Oxford Nanopore Technologies
In other Oxford Nanopore Technologies news, insider Nick Keher acquired 22,018 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was bought at an average cost of GBX 113 per share, with a total value of £24,880.34. In the last three months, insiders have bought 22,799 shares of company stock valued at $2,578,133. Company insiders own 2.54% of the company’s stock.
About Oxford Nanopore Technologies
Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.
Recommended Stories
- Five stocks we like better than Oxford Nanopore Technologies
- AMD’s 5C Deal Positions It as a Direct NVIDIA Rival
- AST SpaceMobile’s Next Launches Could Decide Whether Its Rally Regains Orbit
- 3 Dividend Stocks with Growth on Tap for the Second Half
- 3 Overlooked Stocks Positioned for the Next Market Rotation
Receive News & Ratings for Oxford Nanopore Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Nanopore Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
